Bonfrer JM - Search Results

1

Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlotinib and gefitinib treatment.

Kappers I, Vollebergh MA, van Tinteren H, Korse CM, Nieuwenhuis LL, Bonfrer JM, Klomp HM, van Zandwijk N, van den Heuvel MM. Kappers I, et al. Among authors: bonfrer jm. Ecancermedicalscience. 2010;4:178. doi: 10.3332/ecancer.2010.178. Epub 2010 Nov 3. Ecancermedicalscience. 2010. PMID: 22276032 Free PMC article.

2

Significance of serum S-100B in melanoma patients before and after sentinel node biopsy.

Smit LH, Nieweg OE, Korse CM, Bonfrer JM, Kroon BB. Smit LH, et al. Among authors: bonfrer jm. J Surg Oncol. 2005 May 1;90(2):66-9; discussion 69-70. doi: 10.1002/jso.20238. J Surg Oncol. 2005. PMID: 15844182

3

Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.

van Zandwijk N, Jassem E, Bonfrer JM, Mooi WJ, van Tinteren H. van Zandwijk N, et al. Among authors: bonfrer jm. Semin Oncol. 1992 Feb;19(1 Suppl 2):37-43. Semin Oncol. 1992. PMID: 1329221

4

Monitoring malignant melanoma with the S-100B tumour marker.

Bonfrer JM, Korse CM. Bonfrer JM, et al. Recent Results Cancer Res. 2001;158:149-57. doi: 10.1007/978-3-642-59537-0_15. Recent Results Cancer Res. 2001. PMID: 11092042 Clinical Trial.

5

Non-invasive diagnosis of pleural malignancies: the role of tumour markers.

van den Heuvel MM, Korse CM, Bonfrer JM, Baas P. van den Heuvel MM, et al. Among authors: bonfrer jm. Lung Cancer. 2008 Mar;59(3):350-4. doi: 10.1016/j.lungcan.2007.08.030. Epub 2007 Oct 22. Lung Cancer. 2008. PMID: 17933420

6

TPA and CA 15.3 measurements for breast cancer monitoring in a routine setting.

Bonfrer JM, Korse CM. Bonfrer JM, et al. Int J Biol Markers. 1999 Jan-Mar;14(1):40-4. doi: 10.1177/172460089901400108. Int J Biol Markers. 1999. PMID: 10367249 Free article.

7

Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.

Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P. Bonfrer JM, et al. Anticancer Res. 1997 May-Jun;17(3C):2329-34. Anticancer Res. 1997. PMID: 9245246

8

Serum S-100 has prognostic significance in malignant melanoma.

Bonfrer JM, Korse CM, Israels SP. Bonfrer JM, et al. Anticancer Res. 1997 Jul-Aug;17(4B):2975-7. Anticancer Res. 1997. PMID: 9329579

9

Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma.

van Zandwijk N, Jassem E, Bonfrer JM, van Tinteren H. van Zandwijk N, et al. Among authors: bonfrer jm. Eur J Cancer. 1990 Mar;26(3):373-6. doi: 10.1016/0277-5379(90)90236-m. Eur J Cancer. 1990. PMID: 2162690

10

An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival.

Korse CM, Taal BG, Bonfrer JMG, Vincent A, van Velthuysen ML, Baas P. Korse CM, et al. Among authors: bonfrer jmg. Ann Oncol. 2011 Dec;22(12):2625-2630. doi: 10.1093/annonc/mdr007. Epub 2011 Mar 17. Ann Oncol. 2011. PMID: 21415235 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters